International Psoriasis Council
Advancing Knowledge. Improving Care.
Welcome and Introduction
André Vicente Esteves de Carvalho
COVID-19 and psoriasis
Peter van de Kerkhof
Challenging Case: Linfoma después del tratamiento biológico: ¿Qué fue primero?
Angela Londoño
Challenging Case: Paradoxical psoriasis induced by anti-TNF
Romina Contreras
Challenging Case: To be or not to be? It is not always psoriasis.
Fernando Valenzuela
Challenging Case: Eventos adversos cutáneos durante la terapia biológica.
André Vicente Esteves de Carvalho
Faculty Discussion
All faculty
Closing
Angela Londoño
All RADLA 2021 Videos
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.
